Circulation

Journal

Publication Venue For

  • Association of Cardiovascular Health Through Young Adulthood With Genome-Wide DNA Methylation Patterns in Midlife: The CARDIA Study..  146:94-109. 2022
  • Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants..  146:110-124. 2022
  • Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab..  101161CIRCULATIONAHA12105. 2022
  • Single Nucleus Transcriptomics: Apical Resection in Newborn Pigs Extends the Time Window of Cardiomyocyte Proliferation and Myocardial Regeneration.  145:1744-1747. 2022
  • Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.  145:e153-e639. 2022
  • Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination.  145:345-356. 2022
  • Health Behavior Change Programs in Primary Care and Community Practices for Cardiovascular Disease Prevention and Risk Factor Management Among Midlife and Older Adults: A Scientific Statement From the American Heart Association.  144:e533-e549. 2021
  • Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart Association.  144:e310-e327. 2021
  • SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes.  144:256-266. 2021
  • Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.  144:210-228. 2021
  • Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.  144:E16-E35. 2021
  • Association of Blood Pressure Classification Using the 2017 American College of Cardiology/ American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.  143:2244-2253. 2021
  • Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling after Myocardial Infarction.  143:1317-1330. 2021
  • Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.  143:1109-1122. 2021
  • Gestational Diabetes History and Glucose Tolerance After Pregnancy Associated With Coronary Artery Calcium in Women During Midlife The CARDIA Study.  143:974-987. 2021
  • Heart Disease and Stroke Statistics - 2021 Update: A Report From the American Heart Association.  143:E254-E743. 2021
  • Ten-Year Differences in Women's Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association.  143:E239-E248. 2021
  • Trends in Recurrent Coronary Heart Disease after Myocardial Infarction among US Women and Men between 2008 and 2017.  143:650-660. 2021
  • Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the REGARDS Study.  143:244-253. 2021
  • Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement from the American Heart Association.  E902-E916. 2021
  • A Wide QRS Tachycardia in a 17-Year-Old.  142:2475-2478. 2020
  • The New 2019 AHA/ACC Guideline on the Primary Prevention of Cardiovascular Disease.  142:2402-2404. 2020
  • By Releasing the Brakes with Immunotherapy, Are We Accelerating Atherosclerosis?.  142:2312-2315. 2020
  • Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory from the American Heart Association.  142:E454-E468. 2020
  • Abstract 17244: Obesity and Serial NT-proBNP Levels in Heart Failure: Insights From the GUIDE-IT Trial.  142. 2020
  • Abstract 17284: Geographic Variation in Cardiovascular Health Among American Adults.  142. 2020
  • Response by Schwartz et al to Letter Regarding Article, “Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial”.  142:E335-E336. 2020
  • Forty-Year Shifting Distribution of Systolic Blood Pressure With Population Hypertension Treatment and Control.  142:1524-1531. 2020
  • Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  142:S366-S468. 2020
  • Part 7: Systems of care 2020 american heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.  142:S580-S604. 2020
  • Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.  142:1028-1039. 2020
  • Racial Differences in Serial NT-proBNP Levels in Heart Failure Management: Insights From the GUIDE-IT Trial.  142:1018-1020. 2020
  • Apical Resection Prolongs the Cell Cycle Activity and Promotes Myocardial Regeneration After Left Ventricular Injury in Neonatal Pig.  142:913-916. 2020
  • A Chief Complaint of i Am Going to Die!.  141:1927-1929. 2020
  • Addressing Social Determinants of Health in the Care of Patients with Heart Failure: A Scientific Statement from the American Heart Association.  141:e841-e863. 2020
  • Family Caregiving for Individuals with Heart Failure: A Scientific Statement from the American Heart Association.  141:e864-e878. 2020
  • Knockout of the Murine Ortholog to the Human 9p21 Coronary Artery Disease Locus Leads to Smooth Muscle Cell Proliferation, Vascular Calcification, and Advanced Atherosclerosis.  141:1274-1276. 2020
  • Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients with Chronic Kidney Impairment.  21-33. 2020
  • Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared with Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF.  338-351. 2020
  • Heart disease and stroke statistics—2020 update a report from the American Heart Association.  141:E139-E596. 2020
  • Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity.  1318-1333. 2020
  • Neutrophil-derived S100A8/A9 amplify granulopoiesis after myocardial infarction.  1080-1094. 2020
  • Peripheral Artery Disease and Venous Thromboembolic Events after Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.  1608-1617. 2020
  • Recommendations for cardiovascular health and disease surveillance for 2030 and beyond: A policy statement from the american heart association.  E104-E119. 2020
  • Single-Cell Transcriptomics: New Insights in Heart Research.  1720-1723. 2020
  • Sudden Cardiac Arrest Survivorship: A Scientific Statement from the American Heart Association.  E654-E685. 2020
  • Telecommunicator Cardiopulmonary Resuscitation: A Policy Statement from the American Heart Association.  E686-E700. 2020
  • Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES.  140:2054-2062. 2019
  • The Long and Short of Too Much Drinking.  140:2119-2121. 2019
  • 2019 American Heart Association Focused Update on Advanced Cardiovascular Life Support: Use of Advanced Airways, Vasopressors, and Extracorporeal Cardiopulmonary Resuscitation during Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  140:E881-E894. 2019
  • 2019 American Heart Association Focused Update on Systems of Care: Dispatcher-Assisted Cardiopulmonary Resuscitation and Cardiac Arrest Centers: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  140:E895-E903. 2019
  • Cardiomyocyte Homeodomain-Interacting Protein Kinase 2 Maintains Basal Cardiac Function via Extracellular Signal-Regulated Kinase Signaling.  140:1820-1833. 2019
  • Response by Jia et al to Letter Regarding Article, "high-sensitivity troponin i and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study".  140:E772-E773. 2019
  • Response by Lundberg et al to Letter Regarding Article, "hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity from the Red Blood Cell".  140:E760-E761. 2019
  • Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.  140:1578-1589. 2019
  • Hospital Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International Consortium of Vascular Registries.  140:1285-1287. 2019
  • Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop.  140:1205-1216. 2019
  • Alternating QRS Morphologies and PR Intervals in a Desperately Ill Woman.  140:793-795. 2019
  • Functionally Competent DNA Damage-Free Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair.  140:520-522. 2019
  • Effect of Alirocumab on Mortality after Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.  140:103-112. 2019
  • Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.  140:E69-E89. 2019
  • Response by Bansal et al to Letter Regarding Article, "dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy".  139:E1035-E1036. 2019
  • Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity from the Red Blood Cell.  139:2654-2663. 2019
  • High-Sensitivity Troponin i and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.  139:2642-2653. 2019
  • An Infant With Hemodynamic Collapse.  139:2588-2590. 2019
  • Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.  139:2542-2553. 2019
  • Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies.  139:2422-2436. 2019
  • Unusual Pacing after Electrical Cardioversion.  139:2374-2376. 2019
  • Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.  139:E891-E908. 2019
  • Limitations of Morphological Criteria.  139:1643-1645. 2019
  • Abstract 036: Contemporary Estimates of Obesity Incidence of Among Children in the United States.  139. 2019
  • Abstract P360: Blunted Hemodynamic Response to Acute Mental Stress Among African Americans With Coronary Heart Disease.  139. 2019
  • Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.  139:e56-e528. 2019
  • Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients with Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study.  139:431-443. 2019
  • Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.  139:206-221. 2019
  • Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score: ARIC and MESA.  139:180-191. 2019
  • Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.  139:24-36. 2019
  • Letter by Russell and Janz Regarding Article, "Association Between Early Hyperoxia Exposure After Resuscitation From Cardiac Arrest and Neurological Disability: A Prospective Multicenter Protocol-Directed Cohort Study".  138:2858-2859. 2018
  • 2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  138:e740-e749. 2018
  • Coronary Artery Calcium on Noncontrast Thoracic Computerized Tomography Scans and All-Cause Mortality: Genetic Epidemiology of COPD (COPDGene) Study.  138:2437-2438. 2018
  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.  138:e272-e391. 2018
  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary.  138:e210-e271. 2018
  • Wide QRS Complex After Catheter Ablation..  137:1634-1637. 2018
  • Response by Soliman et al to Letters Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".  137:1300-1301. 2018
  • Heart disease and stroke statistics - 2018 update: A report from the American Heart Association.  137:E67-E492. 2018
  • PCSK9 variants, low-density lipoprotein cholesterol, and neurocognitive impairment reasons for geographic and racial differences in stroke study (REGARDS).  137:1260-1269. 2018
  • Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.  137:e30-e66. 2018
  • Proefferocytic Therapy Promotes Transforming Growth Factor-β Signaling and Prevents Aneurysm Formation..  137:750-753. 2018
  • Early regenerative capacity in the porcine heart.  138:2798-2808. 2018
  • Honoring 50 years of clinical heart transplantation in Circulation: In-depth state-of-the-art review.  137:71-87. 2018
  • Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine.  137:1712-1730. 2018
  • Regenerative potential of neonatal porcine hearts.  138:2809-2816. 2018
  • Supraventricular tachycardia with something missing.  137:2076-2079. 2018
  • Widening racial differences in risks for coronary heart disease.  137:1195-1197. 2018
  • Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease.  136:2325-2336. 2017
  • Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit+ Cells.  136:2359-2372. 2017
  • Increased Inflammation in Pericardial Fluid Persists 48 Hours after Cardiac Surgery.  136:2284-2286. 2017
  • Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.  136:e393-e423. 2017
  • Interleukin-10 inhibits bone marrow fibroblast progenitor cell-mediated cardiac fibrosis in pressure-overloaded myocardium.  136:940-953. 2017
  • Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies a scientific statement from the American Heart Association.  136:e172-e194. 2017
  • Physical activity and prognosis in the TOPCAT trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).  136:982-992. 2017
  • An irregular wide complex tachycardia.  136:773-775. 2017
  • Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension.  136:440-450. 2017
  • Incident cardiovascular disease among adults with blood pressure <140/90 mm Hg.  136:798-812. 2017
  • Black-White Differences in Incident Fatal, Nonfatal, and Total Coronary Heart Disease.  136:152-166. 2017
  • Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk): Insights from the Department of Veterans Affairs.  135:2572-2574. 2017
  • Response by Golwala et al to Letter Regarding Article, "implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".  135:e1200-e1202. 2017
  • Thresholds for Ambulatory Blood Pressure among African Americans in the Jackson Heart Study.  135:2470-2480. 2017
  • Electrocardiogram challenge syncope in a woman with Nausea and Diarrhea.  135:2073-2076. 2017
  • Added sugars and cardiovascular disease risk in children: A scientific statement from the American Heart Association.  135:e1017-e1034. 2017
  • Sources of sodium in US adults from 3 geographic regions.  135:1775-1783. 2017
  • Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (systolic blood pressure intervention trial) intensive blood pressure regimen in the United States: Projections from NHANES (National Health and Nutrition Examination Survey).  135:1617-1618. 2017
  • Heart Disease and Stroke Statistics'2017 Update: A Report from the American Heart Association.  135:e146-e603. 2017
  • Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement from the American Heart Association.  135:e96-e121. 2017
  • Contemporary Assessment of Left Ventricular Diastolic Function in Older Adults: The Atherosclerosis Risk in Communities Study.  135:426-439. 2017
  • Heart Failure Stages among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.  135:224-240. 2017
  • Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.  135:201-203. 2017
  • Revised framingham stroke risk profile to reflect temporal trends.  135:1145-1159. 2017
  • Association between Duration of Resuscitation and Favorable Outcome after Out-of-Hospital Cardiac Arrest: Implications for Prolonging or Terminating Resuscitation.  134:2084-2094. 2016
  • Variations in Abdominal Aortic Aneurysm Care: A Report from the International Consortium of Vascular Registries.  134:1948-1958. 2016
  • Pleiotropic Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors?.  134:1695-1696. 2016
  • Restoration of Hydrogen Sulfide Production in Diabetic Mice Improves Reparative Function of Bone Marrow Cells..  134:1467-1483. 2016
  • Should Patients with Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target?: A Protagonist View from the SPRINT Trial (Systolic Blood Pressure Intervention Trial).  134:1308-1310. 2016
  • Sedentary behavior and cardiovascular morbidity and mortality: A science advisory from the American Heart Association.  134:e262-e279. 2016
  • Updated clinical practice guidelines on heart failure: An international alignment.  134:e280-e281. 2016
  • Response to Letter Regarding Article, "MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis"..  133:e714. 2016
  • Reproductive risk factors and coronary heart disease in the women's health initiative observational study.  133:2149-2158. 2016
  • Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification.  133:1668-1687. 2016
  • Vascular toxicities of cancer therapies: The old and the new - An evolving avenue.  133:1272-1289. 2016
  • Response to Letter Regarding Article, "incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes: A decade in review".  133:e447. 2016
  • Response to Letter Regarding Article, "southern Dietary Pattern is Associated with Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study".  133:e416. 2016
  • SPS3 Evidence Supports Intensive Blood Pressure Control.  133:552-554. 2016
  • Executive summary: Heart disease and stroke statistics-2016 update: A Report from the American Heart Association.  133:447-454. 2016
  • Heart disease and stroke statistics-2016 update a report from the American Heart Association.  133:e38-e48. 2016
  • Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies.  133:256-264. 2016
  • MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis..  133:291-301. 2016
  • Association of fruit and vegetable consumption during early adulthood with the prevalence of coronary artery calcium after 20 years of follow-up.  132:1990-1998. 2015
  • Ideal cardiovascular health during adult life and cardiovascular structure and function among the elderly.  132:1979-1989. 2015
  • Part 4: Systems of care and continuous quality improvement: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care.  132:S397-S413. 2015
  • Part 7: Adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care.  132:S444-S464. 2015
  • Sex-specific association of sleep apnea severity with subclinical myocardial injury, ventricular hypertrophy, and heart failure risk in a community-dwelling cohort.  132:1329-1337. 2015
  • Southern dietary pattern is associated with hazard of acute coronary heart disease in the reasons for geographic and Racial Differences in Stroke (REGARDS) study.  132:804-814. 2015
  • Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone.  132:402-414. 2015
  • Letter by Reddy and Leesar regarding article "assisted beating of the ischemic heart: How to manage the Pulseless st-segment-elevation myocardial infarction patient".  131:e533. 2015
  • The National Physical Activity Plan: A Call to Action from the American Heart Association A Science Advisory from the American Heart Association.  131:1932-1940. 2015
  • Treatment of hypertension in patients with coronary artery disease: A scientific statement from the american heart association, american college of cardiology, and american society of hypertension.  131:e435-e470. 2015
  • Abstract P284: Exploring Differences in Self-Reported Moderate and Vigorous Physical Activity Among Hispanic Subgroups, Non-Hispanic Black, and Non-Hispanic White: National Health Interview Survey (NHIS), 1997-2012.  131:AP284-AP284. 2015
  • Heart disease and stroke statistics-2015 update : A report from the American Heart Association.  131:e29-e39. 2015
  • Adverse childhood experiences and blood pressure trajectories from childhood to young adulthood the georgia stress and heart study.  131:1674-1681. 2015
  • Antibody-mediated rejection in cardiac transplantation: Emerging knowledge in diagnosis and management: A scientific statement from the American Heart Association: Endorsed by the international society for heart and lung transplantation.  131:1608-1639. 2015
  • Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial.  132:27-39. 2015
  • Executive summary: Heart disease and stroke statistics-2015 update : A report from the American Heart Association.  131:434-441. 2015
  • Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes a decade in review.  132:10-19. 2015
  • Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice.  131:1202-1213. 2015
  • Left atrial mural endocarditis secondary to mitral valve jet lesion.  131:1529-1530. 2015
  • Myocardial bridging in a man with non-ST-elevation myocardial infarction.  131:e373-e374. 2015
  • O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.  131:1260-1268. 2015
  • Response to letter regarding article, "the learning curve for transradial percutaneous coronary intervention among operators in the United States: A study from the national cardiovascular data registry".  131:e358. 2015
  • Transdiaphragmatic rupture of hepatic abscess producing purulent pericarditis and pericardial tamponade.  131:e1-e2. 2015
  • Vitamin D therapy in individuals with prehypertension or hypertension the DAYLIGHT trial.  131:254-262. 2015
  • The Practical Use of the Latest Standards of Electrocardiography (PULSE) Trial: Nursing-focused intervention improves nurses' knowledge and quality of ECG monitoring 2014
  • Temporal trends in the population attributable risk for cardiovascular disease: The atherosclerosis risk in communities study.  130:820-828. 2014
  • Epigenome-wide association study of fasting blood lipids in the genetics of lipid-lowering drugs and diet network study.  130:565-572. 2014
  • Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.  130:419-430. 2014
  • Left anterior descending coronary artery occlusion secondary to metastatic squamous cell carcinoma presenting as st-segment-elevation myocardial infarction.  129. 2014
  • Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/-Mice and rabbits fed a high-fat and -cholesterol diet.  129:2403-2413. 2014
  • The learning curve for transradial percutaneous coronary intervention among operators in the united states: A study from the national cardiovascular data registry.  129:2277-2286. 2014
  • Inositol 1,4,5-trisphosphate receptors and human left ventricular myocytes.  129. 2014
  • Racial and regional differences in venous thromboembolism in the United States in 3 cohorts.  129:1502-1509. 2014
  • Application of the American Heart Association/American College of Sports Medicine adult preparticipation screening checklist to a nationally representative sample of US adults aged ≥40 years from the National Health and Nutrition Examination Survey 2001 to 2004.  129:1113-1120. 2014
  • Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.  129:1139-1151. 2014
  • Running forward new frontiers in endurance exercise biology.  129:798-810. 2014
  • Shared decision making in atrial fibrillation where we are and where we should be going.  129:704-710. 2014
  • Executive summary: Heart Disease and Stroke Statistics - 2014 Update: A report from the American Heart Association.  129:399-410. 2014
  • Heart Disease and Stroke Statistics - 2014 Update: A report from the American Heart Association.  129. 2014
  • Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation.  129:266-267. 2014
  • Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.  129:157-172. 2014
  • Association of low-grade albuminuria with adverse cardiac mechanics: Findings from the hypertension genetic epidemiology network (hypergen) study.  129:42-50. 2014
  • CD82 restrains pathological Angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells.  130:1493-1504. 2014
  • Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.  130:e118-e119. 2014
  • High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.  128:2364-2371. 2013
  • Secondary prevention of atherosclerotic cardiovascular disease in older adults: A scientific statement from the American heart association.  128:2422-2446. 2013
  • Age-Associated defects in epha2 signaling impair the migration of human cardiac progenitor cells.  128:2211-2223. 2013
  • Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes.  128:1286-1297. 2013
  • Thymosin β4 increases the potency of transplanted mesenchymal stem cells for myocardial repair.  128. 2013
  • AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: An analysis from the LDL-C assessment with proprotein convertase subtilisin kexin type 9 monoclonal antibody inhibition combined with statin therapy (LAPLACE)-thrombolysis in myocardial infarction (TIMI) 57 Trial.  128:962-969. 2013
  • Pathological ventricular remodeling: Therapies: Part 2 of 2.  128:1021-1030. 2013
  • Exercise standards for testing and training: A scientific statement from the American heart association.  128:873-934. 2013
  • Pathological ventricular remodeling: Mechanisms: Part 1 of 2.  128:388-400. 2013
  • Preliminary experience with social media for community consultation and public disclosure in exception from informed consent trials.  128:267-270. 2013
  • Mechanisms of cell therapy for clinical investigations: An urgent need for large-animal models.  128:92-94. 2013
  • Submassive pulmonary embolism where's the tipping point?.  127:2458-2464. 2013
  • Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention an updated report from the national cardiovascular data registry (2007-2012).  127:2295-2306. 2013
  • Berlin heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children.  127:1702-1711. 2013
  • Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases.  127:1317-1329. 2013
  • US Secular Trends in Coronary Heart Disease, Heart Attack/Myocardial Infarction, and Stroke Prevalence, by Race/Ethnicity, 2005-2010.  127. 2013
  • Right ventricular perforation and pulmonary embolism with polymethylmethacrylate cement after percutaneous kyphoplasty.  127:1251-1253. 2013
  • H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase.  127:1116-1127. 2013
  • Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study.  127:1128-1138. 2013
  • Functional consequences of human induced pluripotent stem cell therapy: Myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.  127:997-1008. 2013
  • Response to letter regarding article, magnetic resonance imaging with 3-dimensional analysis of left ventricular remodeling in isolated mitral regurgitation: Implications beyond dimensions.  127. 2013
  • CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism.  127:63-73. 2013
  • Executive summary: Heart disease and stroke statistics-2013 update: A Report from the American Heart Association.  127:143-152. 2013
  • Heart disease and stroke statistics-2013 update: A Report from the American Heart Association.  127. 2013
  • Synthetic ECG-gated cardiac computed tomography for in vivo imaging of the temporary total artificial heart.  127. 2013
  • The heart disease and stroke statistics-2013 update and the need for a national cardiovascular surveillance system.  127:21-23. 2013
  • Stroke after carotid stenting and endarterectomy in the carotid revascularization endarterectomy versus stenting trial (CREST).  126:3054-3061. 2012
  • Platypnea-orthodeoxia syndrome as a presentation of hereditary hemorrhagic telangiectasia.  126:2645-2647. 2012
  • Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: 2012 update: A statement for health care professionals from the American association of cardiovascular and pulmonary rehabilitation and the American Heart Association.  126:2535-2543. 2012
  • Clinical and angiographic risk stratification and differential impact on treatment outcomes in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial.  126:2115-2124. 2012
  • Coronary artery fistula after cardiac transplantation.  126:2144-2145. 2012
  • Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity.  126:1705-1716. 2012
  • Population approaches to improve diet, physical activity, and smoking habits: A scientific statement from the American heart association.  126:1514-1563. 2012
  • Response to letter regarding article percutaneous coronary intervention in patients with severe aortic stenosis: Implications for transcatheter aortic valve replacement.  126. 2012
  • Ascending-ramp biphasic waveform has a lower defibrillation threshold and releases less troponin i than a truncated exponential biphasic waveform.  126:1328-1333. 2012
  • Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy.  126:1079-1086. 2012
  • Neurodevelopmental outcomes in children with congenital heart disease: Evaluation and management a scientific statement from the american heart association.  126:1143-1172. 2012
  • Cardiac rehabilitation: Call to action for healthcare providers.  126:671-673. 2012
  • Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.  126:418-429. 2012
  • About fACE: Perioperative use of angiotensin-converting enzyme inhibitors.  126:249-251. 2012
  • Energy balance and obesity.  126:126-132. 2012
  • Magnetic resonance imaging with 3-dimensional analysis of left ventricular remodeling in isolated mitral regurgitation: Implications beyond dimensions.  125:2334-2342. 2012
  • Endothelial cells overexpressing interleukin-8 receptors reduce inflammatory and neointimal responses to arterial injury.  125:1533-1541. 2012
  • Increasing referral and participation rates to outpatient cardiac rehabilitation: The valuable role of healthcare professionals in the inpatient and home health settings: A science advisory from the american heart association.  125:1321-1329. 2012
  • Percutaneous coronary intervention in patients with severe aortic stenosis: Implications for transcatheter aortic valve replacement.  125:1005-1013. 2012
  • Myocardial deformation imaging: Current status and future directions.  125. 2012
  • Executive summary: Heart disease and stroke statistics-2012 update: A report from the American heart association.  125:188-197. 2012
  • Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death.  125:65-75. 2012
  • Heart disease and stroke statistics-2012 update: A report from the American heart association.  125. 2012
  • Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS): what have we learned and what will we learn?.  126:1401-1406. 2012
  • Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: A presidential advisory from the american heart association.  124:2951-2960. 2011
  • A Randomized Controlled Trial of beta 1-Receptor Blockade for Chronic Degenerative Mitral Regurgitation.  124. 2011
  • Extracorporeal Membrane Oxygenation Supported Cardiopulmonary Resuscitation Is Not Associated with Increased Survival Compared to Conventional Cardiopulmonary Resuscitation for Pediatric In-Hospital Cardiac Arrest in the United States.  124. 2011
  • Is Small Change Significant? Association of Small Differences in Life's Simple 7 and Mortality: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.  124. 2011
  • Primary outcomes for resuscitation science studies: A consensus statement from the american heart association.  124:2158-2177. 2011
  • Response to letter regarding article, "incidence of sudden cardiac death in national collegiate athletic association athletes".  124. 2011
  • Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).  124:1811-1818. 2011
  • Prevention of overweight/obesity as a strategy to optimize cardiovascular health.  124:840-850. 2011
  • ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the american college of cardiology foundation task force on clinical expert consensus documents.  123:2434-2506. 2011
  • Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association.  123:2292-2333. 2011
  • Transmural heterogeneity and remodeling of ventricular excitation- contraction coupling in human heart failure.  123:1881-1890. 2011
  • Transmural heterogeneity and remodeling of ventricular excitation- contraction coupling in human heart failure.  123:1881-1890. 2011
  • Getting to the heart of myocardial stem cells and cell therapy.  123:1771-1779. 2011
  • Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: Primary results from the folic acid for vascular outcome reduction in transplantation trial.  123:1763-1770. 2011
  • Incidence of sudden cardiac death in national collegiate athletic association athletes.  123:1594-1600. 2011
  • Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A Guideline from the American Heart Association.  123:1243-1262. 2011
  • 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.  123. 2011
  • Heart disease and stroke statistics-2011 update: A report from the American Heart Association.  123. 2011
  • 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): A report of the American college of cardiology foundation/American heart association task force on practice guidelines.  123:104-123. 2011
  • A Prospective Examination of the Obesity Paradox in Heart Failure: Insights from a Population Study.  122. 2010
  • A Prospective Population Study of the Rate and Risk of Hospitalization among Medicare-Eligible Community-Dwelling Older Adults with Incident Heart Failure.  122. 2010
  • Adiposity, Inflammation, and Risk for Death in Black and White Men and Women in the US: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.  122. 2010
  • Colesevelam in Combination with Metformin Significantly Reduces Low-Density Lipoprotein Particle Concentration in Patients with Early Type 2 Diabetes.  122. 2010
  • Increased Protein O-GlcNAcylation Inhibits TNF-alpha-Induced NFkB Signaling in Rat Aortic Smooth Muscle Cells.  122. 2010
  • Inhibition of STIM1 Oligomerization by Protein O-Linked N-Acetylglucosamine: A Novel Metabolically Mediated Regulation of Cardiomyocyte Calcium Overload.  122. 2010
  • Is the Obesity Epidemic Reversing Favorable Trends in Blood Pressure: Evidence from Cohorts Born between 1890 and 1990 in the United States.  122. 2010
  • Life's Simple 7 in 2003-2007 and Mortality in Blacks and Whites: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.  122. 2010
  • Native Endothelium Mimicking Self-Assembled Nanomatrix for Drug-Eluting Stents.  122. 2010
  • Part 8: Adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  122. 2010
  • Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the bypass angioplasty revascularization investigation 2 diabetes trial.  122:1690-1699. 2010
  • Part 6: Defibrillation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations..  122:S325-S337. 2010
  • Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations..  122:S422-S465. 2010
  • Chymase inhibition prevents fibronectin and myofibrillar loss and improves cardiomyocyte function and LV torsion angle in dogs with isolated mitral regurgitation.  122:1488-1495. 2010
  • Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter automatic defibrillator implantation trial: Cardiac resynchronization therapy.  122:985-992. 2010
  • Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.  121:1912-1925. 2010
  • Executive summary: Heart disease and stroke statistics-2010 update: A report from the american heart association.  121. 2010
  • Heart disease and stroke statistics - 2010 update: A report from the American heart association.  121:948-954. 2010
  • Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.  121:252-258. 2010
  • Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes trial.  120:2550-2558. 2009
  • Stem cells for myocardial repair with use of a transarterial catheter.  120. 2009
  • Native Endothelium Mimicking Self-Assembled Nanomatrix for Drug Eluting Stents.  120:S951-S951. 2009
  • Simultaneous Transmural Mapping of Voltage and Calcium in the Human Heart.  120:S667-S667. 2009
  • Simultaneous Transmural Measurements of V-m and Ca-j(2+) During Rapid Pacing and Long-Duration Ventricular Fibrillation in Canine Hearts.  120:S689-S689. 2009
  • ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: A report of the american college of cardiology foundation/american heart association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): Developed in collaboration with the american academy of family physicians.  120:1296-1336. 2009
  • Regulation of vascular contractility and blood pressure by the E2F2 transcription factor.  120:1213-1221. 2009
  • Mortality, health outcomes, and body mass index in the overweight range: A science advisory from the american heart association.  119:3263-3271. 2009
  • Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity.  119:2818-2828. 2009
  • Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.  119:2545-2552. 2009
  • Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American heart association.  119:2408-2416. 2009
  • MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20.  119:2357-2366. 2009
  • Molecular cardiology microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog.  119:2086-2095. 2009
  • Distribution and Determinants of Doppler-Derived Diastolic Flow Indices in African Americans: The Jackson Heart Study.  119:E340-E340. 2009
  • Divergent tumor necrosis factor receptor-related remodeling responses in heart failure:Role of nuclear factor-κB and inflammatory activation.  119:1386-1397. 2009
  • Racial and Geographic Differences in Self-Reported Moderate or More Physical Activity: The REasons for Geographic And Racial Differences in Stroke (REGARDS).  119:E344-E344. 2009
  • Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention..  119:1056-1065. 2009
  • Heart disease and stroke statistics - 2009 update. A report from the American heart association statistics committee and stroke statistics subcommittee.  119:480-486. 2009
  • Heart disease and stroke statistics - 2009 update. A report from the American heart association statistics committee and stroke statistics subcommittee.  119:480-486. 2009
  • Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease. The coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis.  119:382-389. 2009
  • Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition.  118:1970-1978. 2008
  • Natural Endothelium Mimicking Self-Assembled Nanomatrix for Drug Eluting Stent Applications.  118:S962-S962. 2008
  • Transition from chronic compensated to acute d compensated heart failure: Pathophysiological insights obtained from continuous monitoring of intracardiac pressures.  118:1433-1441. 2008
  • Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: Results of the multicenter trial of the orqis medical cancion system for the enhanced treatment of heart failure unresponsive to medical therapy (MOMENTUM).  118:1241-1249. 2008
  • Population-based prevention of obesity: The need for comprehensive promotion of healthful eating, physical activity, and energy balance: A scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for prevention (formerly the expert panel on population and prevention science).  118:428-464. 2008
  • Marginally increased waist circumference predicts hypertension prevalence among normal and overweight adults: The REGARDS study.  117. 2008
  • Angina pectoris: Reversal of the gender gap.  117:1505-1507. 2008
  • Heart disease and stroke statistics-2008 Update: A report from the American heart association statistics committee and stroke statistics subcommittee.  117. 2008
  • Heme oxygenase-1 and carbon monoxide in vascular pathobiology: Focus on angiogenesis.  117:231-241. 2008
  • Proarrhythmic aspects of atrial fibrillation surgery: Mechanisms of postoperative macroreentrant tachycardias.  117:155-162. 2008
  • CD36 expression contributes to age-induced cardiomyopathy in mice.  116:2139-2147. 2007
  • Activation patterns of Purkinje fibers during long-duration ventricular fibrillation in an isolated canine heart model.  116:1113-1119. 2007
  • Resistance exercise in individuals with and without cardiovascular disease: 2007 update: A scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism.  116:572-584. 2007
  • Core components of cardiac rehabilitation/secondary prevention programs: 2007 update - A sci. statement from the Am. Heart Assoc. exercise, cardiac rehabilitation, and prevention comm., the council on clinical cardiology; the councils on cardiovascular nursing, epidemiology and prevention, and nutrition, physical activity, and metabolism; and the Am. Assoc. of Cardiovasc. and Pulmonary Rehabil..  115:2675-2682. 2007
  • Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: Effects on macrophage recruitment, nuclear factor-κB nuclear translocation, and foam cell death.  115:2442-2450. 2007
  • Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention.  115:2761-2788. 2007
  • Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.  115:1866-1875. 2007
  • Evidence-based guidelines for cardiovascular disease prevention in women: 2007 Update.  115:1481-1501. 2007
  • Medication adherence does not explain disparities in blood pressure control: The reasons for geographic and racial differences in stroke (REGARDS) study.  115:E288-E288. 2007
  • Perceived stress and depression: The impact of race and residence in the "Black Belt" region of the Southeastern United States.  115:E275-E276. 2007
  • The national prevalence of healthy lifestyles is low and varies by race and geographic region.  115:E280-E280. 2007
  • Trust in the patient-physician relationship is related to care-seeking behavior following stroke symptoms: The REasons for geographic and racial differences in stroke (REGARDS) study.  115:E259-E260. 2007
  • Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: The coronary artery risk development in young adults study.  115:1004-1011. 2007
  • Effect of high-dose atorvastatin on hospitalizations for heart failure: Subgroup analysis of the Treating to New Targets (TNT) study.  115:576-583. 2007
  • Heart disease and stroke statistics - 2007 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.  115. 2007
  • Indications for heart transplantation in pediatric heart disease: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group.  115:658-676. 2007
  • Tumor necrosis factor-α receptor p75 is required in ischemia-induced neovascularization.  115:752-762. 2007
  • Essential features of a surveillance system to support the prevention and management of heart disease and stroke: A scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease.  115:127-155. 2007
  • Trends in acute myocardial infarction in 4 US States between 1992 and 2001: Clinical characteristics, quality of care, and outcomes.  114:2806-2814. 2006
  • Estrogen receptors α and β mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.  114:2261-2270. 2006
  • Continuity of epicardial activation during ventricular fibrillation in the isolated swine heart.  114:330-330. 2006
  • Protein O-glycosylation improves survival and effects cytokine release following trauma-hemorrhage in rats.  114:426-426. 2006
  • Relationship between aspirin, statins, the combination and C-reactive protein.  114:828-829. 2006
  • Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury.  114:1721-1728. 2006
  • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation).  114:700-752. 2006
  • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation).  114. 2006
  • Human ventricular fibrillation: Wandering wavelets, mother rotors, or both?.  114:530-532. 2006
  • The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.  114:894-904. 2006
  • Outcome of listing for cardiac transplantation for failed Fontan: A multi-institutional study.  114:273-280. 2006
  • Outcomes of children bridged to heart transplantation with ventricular assist devices: A multi-institutional study.  113:2313-2319. 2006
  • Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms.  113:1888-1904. 2006
  • Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9.  113:1605-1614. 2006
  • Pulsology rediscovered: Commentary on the Conduit Artery Function Evaluation (CAFE) study.  113:1162-1163. 2006
  • Racial differences in intensity of hypertension treatment: The reasons for geographic and racial disparities in stroke study.  113:E309-E309. 2006
  • Relationship for stroke and heart disease between the average Framingham Risk Scores with cause-specific mortality at the state level.  113:E312-E312. 2006
  • Heart disease and stroke statistics - 2006 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.  113. 2006
  • Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.  113:544-554. 2006
  • Standards for statistical models used for public reporting of health outcomes: An American Heart Association scientific statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group.  113:456-462. 2006
  • ICAM-1 governs angiogenesis via regulation of eNOS activity: Role of glutathione and PTEN.  112:U156-U156. 2005
  • Modified lipoprotein-immune complexes and progression of internal carotid intima-media thickness in type 1 diabetes.  112:U848-U849. 2005
  • Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice.  112:2668-2676. 2005
  • Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity.  112:2686-2695. 2005
  • Mutations in transforming growth factor-β receptor type II cause familial thoracic aortic aneurysms and dissections.  112:513-520. 2005
  • Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.  112:93-102. 2005
  • Apolipoprotein E mimetic peptide dramatically lowers plasma cholesterol and restores endothelial function in Watanabe heritable hyperlipidemic rabbits.  111:3112-3118. 2005
  • Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests.  111:2565-2571. 2005
  • Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart.  111:2066-2072. 2005
  • Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: The LIFE (Losartan Intervention for Endpoint reduction in hypertension) study.  111:1924-1931. 2005
  • Differences in predicted 10-year risk of stroke by region and race.  111:E212-E213. 2005
  • High prevalence of stroke symptoms in a general population without a history of stroke or TIA: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  111:E213-E213. 2005
  • National distribution of C-reactive protein in African-Americans and whites: The reasons for geographic and racial differences in stroke (REGARDS) study.  111:E226-E226. 2005
  • Gender and peri-procedural stroke and death following carotid artery stenting: An update from the CREST lead-in phase.  111:E49-E49. 2005
  • Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model.  111:150-156. 2005
  • Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apolipoprotein E-/- mice fed a chow diet.  110:3715-3720. 2004
  • D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.  110:3252-3258. 2004
  • Restitution properties during ventricular fibrillation in the in situ swine heart.  110:3161-3167. 2004
  • Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis.  110:2831-2836. 2004
  • Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group II: age-dependent risk factors for obesity and comorbidities..  110. 2004
  • Protection from ischemic and hypovolemic injury by hyperglycemia transduced by hexosamine biosynthesis and O-linked N-acetylglucosamine on cytoplasmic proteins.  110:1099-1099. 2004
  • Role of microscopic tissue structure in shock-induced activation assessed by optical mapping in myocyte cultures.  110:98-98. 2004
  • Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.  110:1960-1966. 2004
  • Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries.  110:1664-1669. 2004
  • Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.  110:292-300. 2004
  • Electrophysiological findings in adolescents with atrial fibrillation who have structurally normal hearts.  110:117-123. 2004
  • Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study.  110:74-78. 2004
  • Hypertensive therapy: Part I.  109:2953-2958. 2004
  • Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).  109:2993-2999. 2004
  • Air pollution and cardiovascular disease: A statement for healthcare professionals from the expert panel on population and prevention science of the American Heart Association.  109:2655-2671. 2004
  • Neurological events during long-term mechanical circulatory support for heart failure: The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience.  109:2423-2427. 2004
  • Short-acting β-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation.  109:2469-2474. 2004
  • Intramural virtual electrodes in ventricular wall: Effects on epicardial polarizations.  109:2349-2356. 2004
  • Resumption of Electrical Conduction in Previously Isolated Pulmonary Veins: Rationale for a Different Strategy?.  109:1226-1229. 2004
  • Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report from the Women's Ischemia Syndrome Evaluation (WISE) Study.  109:706-713. 2004
  • Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women.  109:672-693. 2004
  • Estradiol and Progestins Differentially Modulate Leukocyte Infiltration after Vascular Injury.  109:234-241. 2004
  • Hypertensive therapy: Part II..  109:3081-3088. 2004
  • Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice..  109:3215-3220. 2004
  • Influenza and Cardiovascular Disease: A New Opportunity for Prevention and the Need for Further Studies.  108:2730-2736. 2003
  • Does the stroke risk of stenting increase at older ages? Thirty-day stroke - Death rates in the CREST lead-in phase.  108:461-461. 2003
  • Increased oxidation of free fatty acids does not lead to increased susceptibility to ischemia in hearts from type-2 diabetic rats.  108:17-17. 2003
  • Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels.  108:2000-2006. 2003
  • From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II.  108:1772-1778. 2003
  • From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I.  108:1664-1672. 2003
  • Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice.  108:754-759. 2003
  • Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor.  108:598-604. 2003
  • Evidence for longitudinal and transverse fiber conduction in human pulmonary veins: Relevance for catheter ablation.  108:590-597. 2003
  • β1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation.  108:225-230. 2003
  • Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: Enhancement by tissue necrosis factor-α, interleukin-1β, and interferon-γ.  107:1545-1549. 2003
  • A test of an innovative approach to develop a national cohort to address racial and geographic disparities in stroke.  107:E7020-E7021. 2003
  • Five-year changes in carotid intimal-medial thickness are highly correlated between arteries and among wall segments.  107:E7036-E7036. 2003
  • Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: Implications in the antiproliferative response to rapamycin.  107:911-916. 2003
  • Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice.  107:762-768. 2003
  • Use of emergency medical services in acute myocardial infarction and subsequent quality of care: Observations from the national registry of myocardial infarction 2.  106:3018-3023. 2002
  • Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).  106:2537-2542. 2002
  • Differential modulation of lactate, pyruvate and glucose oxidation by insulin and dichloroacetate.  106:195-196. 2002
  • Optical mapping of V-m and Ca-i(2+) during arrhythmias induced by local perfusion of norepinephrine in cultured cell monolayers.  106:192-192. 2002
  • Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.  106:1127-1132. 2002
  • Intramural virtual electrodes during defibrillation shocks in left ventricular wall assessed by optical mapping of membrane potential.  106:1007-1014. 2002
  • Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va..  106:836-841. 2002
  • Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.  106:854-859. 2002
  • Mitochondrial integrity and function in atherogenesis.  106:544-549. 2002
  • Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure.  106:407-411. 2002
  • Defending the rationale for the two-tailed test in clinical research.  105:3062-3065. 2002
  • Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/progestin Replacement Study (HERS).  105:2962-2967. 2002
  • Mild renal insufficiency is associated with angiographic coronary artery disease in women.  105:2826-2829. 2002
  • Impact of myocardial ischemia and reperfusion on ventricular defibrillation patterns, energy requirements, and detection of recovery.  105:2537-2542. 2002
  • Intracellular Na+ concentration is elevated in heart failure but Na/K pump function is unchanged.  105:2543-2548. 2002
  • Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation.  105:2253-2258. 2002
  • Adaptation and maladaptation of the heart in diabetes: Part II: Potential mechanisms.  105:1861-1870. 2002
  • Adaptation and maladaptation of the heart in diabetes: Part I. General concepts.  105:1727-1733. 2002
  • BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.  105:1348-1353. 2002
  • Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues.  105:849-854. 2002
  • Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.  105:290-292. 2002
  • Metabolic gene expression in fetal and failing human heart.  104:2923-2931. 2001
  • Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: Evidence from the mouse carotid artery ligation model.  104:2740-2745. 2001
  • Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction.  104:2641-2644. 2001
  • ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation).  104:2118-2150. 2001
  • Association of a gene polymorphism for PAI-1 with primary pulmonary hypertension.  104:604-604. 2001
  • c-Jun decreases voltage-gated K+ channel activity in pulmonary artery smooth muscle cells.  104:1557-1563. 2001
  • Normalized diastolic properties after left ventricular assist result from reverse remodeling of chamber geometry.  104. 2001
  • Mechanism of ventricular defibrillation for near-defibrillation threshold shocks: A whole-heart optical mapping study in swine.  104:1313-1319. 2001
  • Right atrial septal electrode for reducing the atrial defibrillation threshold.  104:1066-1070. 2001
  • Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: A primary role of mechanical unloading underlying reverse remodeling.  104:670-675. 2001
  • Genetic and environmental contributions to platelet aggregation: The Framingham Heart Study.  103:3051-3056. 2001
  • Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty.  103:2935-2941. 2001
  • High-energy phosphate metabolism and creatine kinase in failing hearts: A new porcine model.  103:1570-1576. 2001
  • Improvement of defibrillation efficacy and quantification of activation patterns during ventricular fibrillation in a canine heart failure model.  103:1473-1478. 2001
  • Insulin resistance and five-year progression of carotid intimal-medial wall thickness: The Insulin Resistance Atherosclerosis Study (IRAS).  103:1349-1349. 2001
  • Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.  103:1012-1016. 2001
  • Hormone replacement therapy and stroke: Are the results surprising?.  103:620-622. 2001
  • Primary prevention of ischemic stroke: A statement for healthcare professionals from the stroke council of the American Heart Association.  103:163-182. 2001
  • Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure.  102:2713-2719. 2000
  • Reduction of atrial defibrillation threshold with an interatrial septal electrode.  102:2659-2664. 2000
  • Microcirculatory effects of blocking cell adhesion molecules in transgenic sickle cell mice..  102:307-307. 2000
  • Septum acts as a partial barrier to wavefronts during ventricular fibrillation.  102:341-341. 2000
  • Shock-induced arrhythmias assessed using mapping of transmembrane potential and intracellular calcium in myocyte cultures.  102:341-341. 2000
  • The role of calcium current in the nonlinear changes of transmembrane potential during defibrillation shocks.  102:340-340. 2000
  • Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (IRAS).  102:42-47. 2000
  • Estrogen attenuates integrin-β3-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.  101:2949-2955. 2000
  • Left ventricular apex ablation decreases the upper limit of vulnerability.  101:2458-2460. 2000
  • Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression.  101:2338-2341. 2000
  • Estrogen-induced vasoprotection is estrogen receptor dependent: Evidence from the balloon-injured rat carotid artery model.  101:2342-2344. 2000
  • Mechanism of ventricular defibrillation: The role of tissue geometry in the changes in transmembrane potential in patterned myocyte cultures.  101:2438-2445. 2000
  • beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling..  101:2103-2109. 2000
  • β-Adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.  101:2103-2109. 2000
  • Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs.  101:1736-1742. 2000
  • Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries.  101:1362-1365. 2000
  • Influence of postshock epicardial activation patterns on initiation of ventricular fibrillation by upper limit of vulnerability shocks.  101:1329-1336. 2000
  • Pacing after shocks stronger than the upper limit of vulnerability: Impact on fibrillation induction.  101:1337-1343. 2000
  • Ventricular defibrillation with triphasic waveforms.  101:1324-1328. 2000
  • Clinical outcomes after ablation and pacing therapy for atrial fibrillation: A meta-analysis.  101:1138-1144. 2000
  • Prevention of high incidence of neurally mediated ventricular arrhythmias by afferent nerve stimulation in dogs.  101:819-824. 2000
  • Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias: Evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias.  101:624-630. 2000
  • Essential hypertension part II: Treatment.  101:446-453. 2000
  • Essential hypertension. Part I: Definition and etiology.  101:329-335. 2000
  • Bradykinin in the heart: Friend or foe?.  100:2305-2307. 1999
  • Risks of spontaneous injury and extraction of an active fixation pacemaker lead: Report of the accufix multicenter clinical study and worldwide registry.  100:2344-2352. 1999
  • Subtype specific regulation of human vascular α1-adrenergic receptors by vessel bed and age.  100:2336-2343. 1999
  • Harriet Pearson Dustan..  100:2122-2123. 1999
  • Anisotropy of membrane polarization decreases when an electrode is separated from the myocardial surface.  100:786-786. 1999
  • Electrotonic suppression of early and delayed afterdepolarizations in electrically coupled, isolated ventricular myocytes.  100:846-846. 1999
  • Heart failure changes activation patterns during ventricular fibrillation.  100:838-839. 1999
  • Organizational changes in atrial fibrillation produced by a single radiofrequency ablation lesion remain local to the lesion site.  100:341-342. 1999
  • Primary prevention of high blood cholesterol in the US, 1887-1994.  100:740-740. 1999
  • Radiofrequency ablation of the right atrium reduces atrial defibrillation thresholds and changes fibrillatory activity.  100:65-65. 1999
  • Ventricular fibrillation characteristics are different in different species.  100:310-310. 1999
  • Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.  100:1639-1645. 1999
  • Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension.  99:3266-3271. 1999
  • Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo.  99:2583-2589. 1999
  • Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement..  99:2480-2484. 1999
  • Guide to preventive cardiology for women.  99:2480-2484. 1999
  • Women versus men regarding outcome of CABG or PTCA [6] (multiple letters).  99:1925-1926. 1999
  • Carotid artery elasticity varies directly with educational achievement level: The ARIC Study, 1987-1992..  99:1112-1112. 1999
  • Insulin sensitivity and systemic atherosclerosis.  99:1115-1115. 1999
  • Predictors of inflammatory status in a middle-aged population.  99:1108-1108. 1999
  • Trends in severity of hospitalized myocardial infarction: The ARIC study 1987-1994..  99:1104-1104. 1999
  • Myocardial oxygenation during high work states in hearts with postinfarction remodeling.  99:942-948. 1999
  • Automated heparin-delivery system to control activated partial thromboplastin time: Evaluation in normal volunteers.  99:751-756. 1999
  • Identification of a novel genetic locus for familial cardiac myxomas and Carney complex.  98:2560-2566. 1998
  • Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy.  98:2404-2414. 1998
  • Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease.  98:2248-2254. 1998
  • Relative efficacy of monophasic and biphasic waveforms for transthoracic defibrillation after short and long durations of ventricular fibrillation.  98:2210-2215. 1998
  • ACE-I therapy improves 30-day survival in Medicare patients recently hospitalized with congestive heart failure (CHF).  98:811-812. 1998
  • Alterations of intra-myocyte ion content correlate with post-cardioplegia electrophysiologic recovery.  98:750-750. 1998
  • Effect of defibrillation shocks on transmembrane potential in strands of cultured myocytes.  98:52-52. 1998
  • In vivo cardiac energetics in GLUT4-null mice.  98:627-628. 1998
  • Primary prevention of high blood pressure in the US, 1959-1994..  98:657-657. 1998
  • Pulmonary vein stenosis after catheter ablation of atrial fibrillation.  98:1769-1775. 1998
  • Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads.  98:1517-1524. 1998
  • Better outcome for women compared with men undergoing coronary revascularization: A report from the bypass angioplasty revascularization investigation (BARI).  98:1279-1285. 1998
  • Adenosine-induced preconditioning of human myocardium? [2] (multiple letters).  98:824-825. 1998
  • Images in cardiovascular medicine. Improvement of myocardial perfusion after transmyocardial laser revascularization and coronary artery bypass graft surgery..  98:728-729. 1998
  • Marked reduction in internal atrial defibrillation thresholds with dual- current pathways and sequential shocks in humans.  97:2527-2535. 1998
  • Adenosine pretreatment of human myocardium and ischemic preconditioning [2] (multiple letters).  97:2279. 1998
  • Pathophysiology of sudden coronary death in women: Implications for prevention.  97:2103-2105. 1998
  • Evidence for association and genetic linkage of the angiotensin- converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study.  97. 1998
  • Myocardial discontinuities: A substrate for producing virtual electrodes that directly excite the myocardium by shocks.  97:1738-1745. 1998
  • Locally propagated activation immediately after internal defibrillation.  97:1401-1410. 1998
  • Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2.  97:1150-1156. 1998
  • Atherosclerosis in type 2 diabetic and non-diabetic subjects with and without previous myocardial infarction: The insulin resistance atherosclerosis study (IRAS).  97:817-817. 1998
  • Could a decrease in the correlation between CVD risk factors underlie their smaller estimated impact on CVD in the elderly?.  97:823-823. 1998
  • Effect of postmenopausal hormone therapy on carbohydrate metabolism.  97:831-831. 1998
  • Stroke incidence rates: Seven year follow-up of the atherosclerosis risk in communities (ARIC) cohort.  97:824-824. 1998
  • The multiple metabolic syndrome: Increased clustering versus increased prevalence?.  97:831-831. 1998
  • Left ventricular thrombus.  97:412. 1998
  • Carotid stenting and angioplasty: A statement for healthcare professionals from the councils on cardiovascular radiology, stroke, cardio- thoracic and vascular surgery, epidemiology and prevention, and clinical cardiology, American Heart Association.  97:121-123. 1998
  • No role for NO in estrogen-mediated vasoprotection?.  96:2769-2771. 1997
  • Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery.  96. 1997
  • Effects of biphasic shocks on the spatial distribution of the transmembrane potential.  96:688-688. 1997
  • Excitation of cardiac tissue by defibrillation shocks: Role of microscopic tissue geometry.  96:683-683. 1997
  • Internal cardioversion of atrial fibrillation: Marked reduction in defibrillation threshold with dual current pathways.  96:2693-2700. 1997
  • Intravenous amiodarone increases ventricular fibrillation organization without increasing wavelength.  96:4188-4188. 1997
  • L-arginine protects against xanthine oxidase-dependent vascular injury in hypercholesterolemic rabbits.  96:2327-2327. 1997
  • Quantitative characteristic of reentrant pathways change during the first 44 seconds of ventricular fibrillation.  96:687-687. 1997
  • Local delivery of ethanol inhibits intimal hyperplasia in pig coronary arteries after balloon injury.  96:2295-2301. 1997
  • Myocardial infarction and cardiac mortality in the bypass angioplasty revascularization investigation (BARI) randomized trial.  96:2162-2170. 1997
  • Estrogen restores endothelial cell function in an experimental model of vascular injury.  96:1624-1630. 1997
  • Effects of transvenous electrode polarity and waveform duration on the relationship between defibrillation threshold and upper limit of vulnerability.  96:1351-1359. 1997
  • Regional disparities in the incidence of elevated blood pressure among young adults: The CARDIA study.  96:1082-1088. 1997
  • Relationships between myocardial bioenergetic and left ventricular function in hearts with volume-overload hypertrophy.  96:334-343. 1997
  • Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group..  95:1479-1486. 1997
  • Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension.  95:1479-1486. 1997
  • Elective stenting of the extracranial carotid arteries.  95:376-381. 1997
  • Preconditioning of human myocardium with adenosine during coronary angioplasty.  95:2500-2507. 1997
  • Prediction of outcome of patients with life-threatening ventricular arrhythmias treated with automatic implantable cardioverter-defibrillators using SPECT perfusion imaging.  95:390-394. 1997
  • Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment.  95:1301-1307. 1997
  • Termination of ventricular tachycardia in the human heart: Insights from three-dimensional mapping of nonsustained and sustained ventricular tachycardias.  95:2528-2540. 1997
  • Three-dimensional mapping of the initiation of nonsustained ventricular tachycardia in the human heart.  95:2517-2527. 1997
  • Transesophageal echocardiographic assessment of papillary muscle rupture [6] (multiple letters).  96:2737-2738. 1997
  • Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database Group..  94:2883-2889. 1996
  • Outcome of cardiac transplantation in children. Survival in a contemporary multi-institutional experience. Pediatric Heart Transplant Study..  94:II69-II73. 1996
  • Outcome of cardiac transplantation in children: Survival in a contemporary multi-institutional experience.  94. 1996
  • Differential postshock activation pattern of successful and failed defibrillation shocks of the same shock strength.  94:3325-3325. 1996
  • Quantitative analysis of the effects of dofetilide on ventricular fibrillation activation fronts and its relationship to defibrillation threshold in pigs.  94:1429-1429. 1996
  • Stationary reentrant circuits are rare during ventricular fibrillation in pigs.  94:271-271. 1996
  • Insulin Sensitivity and Atherosclerosis.  93:1809-1817. 1996
  • Insulin sensitivity and atherosclerosis.  93:1809-1817. 1996
  • Management of patients with atrial fibrillation: A statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology, American Heart Association.  93:1262-1277. 1996
  • Relation between activated clotting time during angioplasty and abrupt closure.  93:667-671. 1996
  • Enhanced regional deformation at the anterior papillary muscle insertion site after chordal transsection.  93:585-593. 1996
  • Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery.  93:577-584. 1996
  • Ethnic differences in carotid wall thickness: The insulin resistance atherosclerosis study (IRAS).  93:P25-P25. 1996
  • Passive and active smoking are related to progression or atherosclerosis.  93:22-22. 1996
  • Asymptomatic cardiac ischemia pilot (ACIP) study: Relationship between exercise-induced and ambulatory ischemia in patients with stable coronary disease.  94:1537-1544. 1996
  • Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias.  94:1585-1591. 1996
  • Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model MRI and 31P-MRS study.  94:1089-1100. 1996
  • Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery.  94:2221-2227. 1996
  • Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994: A multi-institutional study.  94:2883-2889. 1996
  • Transesophageal echocardiographic assessment of papillary muscle rupture.  94:1003-1009. 1996
  • Selection and treatment of candidates for heart transplantation: A statement for health professionals from the committee on heart failure and cardiac transplantation of the council on clinical cardiology, American Heart Association.  92:3593-3612. 1995
  • Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations.  92:3082-3088. 1995
  • Asymptomatic cardiac ischemia pilot (ACIP) study: Improvement of cardiac ischemia at 1 year after PTCA and CABG.  92. 1995
  • Postextrasystolic mechanical restitution in closed-chest dogs: Effect of heart failure.  92:2652-2659. 1995
  • ANODAL AND CATHODAL POINT STIMULATION PRODUCE ACTION-POTENTIAL PROLONGATION IN REGIONS OF DEPOLARIZATION.  92:1431-1431. 1995
  • DIRECT LINK BETWEEN GAP JUNCTION REMODELING AND CHANGES IN CONDUCTION IN CULTURED MYOCYTES.  92:189-189. 1995
  • RELATION BETWEEN GAP JUNCTION DISTRIBUTION AND ANISOTROPIC ACTIVATION SPREAD IN CULTURED MONOLAYERS OF NEONATAL RAT MYOCYTES.  92:188-188. 1995
  • Effects of premature beats on repolarization of postextrasystolic beats.  92:1969-1980. 1995
  • Endocardial carbon-braid electrodes: A new concept for lower defibrillation thresholds.  92:1627-1633. 1995
  • Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves.  92:1291-1299. 1995
  • Bioenergetic consequences of left ventricular remodeling.  92:1011-1019. 1995
  • Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits.  92:1034-1048. 1995
  • The risk of atrial fibrillation following radiofrequency catheter ablation of atrial flutter.  92:430-435. 1995
  • Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis: Results from the TIMI II study.  91:2541-2548. 1995
  • Cardiovascular health at the crossroads: outlook for the 21st century. Presented at the 67th Scientific Sessions of the American Heart Association November 4, 1994 Dallas, Texas..  91:1304-1310. 1995
  • Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system.  91:1247-1252. 1995
  • DOES THE ASSOCIATION OF RISK-FACTORS AND ATHEROSCLEROSIS CHANGE WITH AGE - A COMBINED ANALYSIS OF THE ARIC AND CHS COHORTS.  91:931-931. 1995
  • IS THE STROKE BELT DISAPPEARING - AN ANALYSIS OF RACIAL AND TEMPORAL EFFECTS.  91:938-938. 1995
  • Improved defibrillation threshold with a new epicardial carbon electrode compared with a standard epicardial titanium patch.  91:445-450. 1995
  • Coarctation of the aorta and ventricular septal defect.  91:1263. 1995
  • Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake: A 31P NMR spectroscopic study.  92:1274-1283. 1995
  • Effect of tachycardia heart failure on the restitution of left ventricular function in closed-chest dogs.  91:176-185. 1995
  • Fighting the NIH funding crisis.  91:2502. 1995
  • Preventing heart attack and death in patients with coronary disease.  92:2-4. 1995
  • 2-DIMENSIONAL HIGH-RESOLUTION OPTICAL MAPPING OF ANISOTROPIC IMPULSE CONDUCTION IN NEONATAL RAT-HEART CEL MONOLAYERS.  90:40-40. 1994
  • CALCULATION OF ABSOLUTE METABOLIC FLUXES IN THE PERFUSED RAT-HEART BY C-13 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY.  90:629-629. 1994
  • CONDUCTION-VELOCITY AND SHAPE OF ACTION-POTENTIAL UPSTROKE IN A COMPUTER-MODEL OF AN ANISOTROPIC HEART CELL MONOLAYER.  90:411-411. 1994
  • PLASMA-CONCENTRATIONS OF LP(A) DISTINGUISH FEMALE BUT NOT MALE CORONARY-DISEASE CASES FROM CONTROLS.  90:509-509. 1994
  • Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction..  90:2103-2114. 1994
  • RACIAL-DIFFERENCES IN CAROTID-ARTERY WALL THICKNESS IN MIDDLE-AGED ADULTS.  89:939-939. 1994
  • SOCIOECONOMIC-STATUS AFFECTS THE EXCESS BLACK STROKE MORTALITY - THE NATIONAL-LONGITUDINAL-MORTALITY-STUDY.  89:939-939. 1994
  • Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy.  90:1441-1458. 1994
  • Intramachine and intermachine variability in transesophageal color Doppler images of pulsatile jets: In vitro studies.  89:2141-2149. 1994
  • Magnetic resonance imaging of chronic myocardial infarcts in formalin- fixed human autopsy hearts.  89:2133-2140. 1994
  • Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo.  90:2468-2473. 1994
  • Scar remodeling and transmural deformation after infarction in the pig.  90:411-420. 1994
  • Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the National Registry of Myocardial Infarction.  90:2103-2114. 1994
  • Influence of left ventricular assist on valvular regurgitation..  88:II309-II318. 1993
  • Report of the task force on children and youth. American Heart Association..  88:2479-2486. 1993
  • Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial..  88:1484-1494. 1993
  • TISSUE GEOMETRY AS A DETERMINANT OF UNIDIRECTIONAL CONDUCTION BLOCK - ASSESSMENT OF MICROSCOPIC EXCITATION SPREAD BY OPTICAL MAPPING IN PATTERNED MYOCYTE CULTURES.  88:623-623. 1993
  • Internal cardioversion of atrial fibrillation in sheep.  87:1673-1686. 1993
  • Race and prognosis after myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial.  88:1484-1494. 1993
  • Report of the task force on children and youth.  88:2479-2485. 1993
  • Failure of cryopreserved homograft valved conduits in the pulmonary circulation..  86:II150-II153. 1992
  • Rejection after cardiac transplantation. A time-related risk factor analysis..  86:II236-II241. 1992
  • Surgical connections from ventricle to pulmonary artery. Comparison of four types of valved implants..  86:II154-II158. 1992
  • ALTERATIONS IN MYOCARDIAL GLUCOSE-METABOLISM IN DIABETES-INDUCED HEART-FAILURE.  86:281-281. 1992
  • DISCONTINUOUS IMPULSE PROPAGATION AT A CELLULAR-LEVEL IN CULTURED STRANDS OF NEONATAL RAT-HEART CELLS.  86:752-752. 1992
  • OPTICAL VERSUS ELECTRICAL DETECTION OF RAPID MEMBRANE-POTENTIAL CHANGES IN CULTURED NEONATAL RAT-HEART CELLS.  86:820-820. 1992
  • PASSIVE SMOKING AND CAROTID-ARTERY WALL THICKNESS - THE ARIC STUDY.  85:862-862. 1992
  • Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure: Results of a multicenter trial.  85:942-949. 1992
  • Cardiac potential and potential gradient fields generated by single, combined, and sequential shocks during ventricular defibrillation.  85:1510-1523. 1992
  • Cardiac transplantation: Recipient selection, donor procurement, and medical follow-up: A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association.  86:1061-1079. 1992
  • Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study.  86:1206-1216. 1992
  • Contribution of myocardium responsible for ventricular tachycardia to abnormalities detected by analysis of signal-averaged ECGs.  86:1888-1901. 1992
  • Coronary angioplasty in cardiac transplant patients: Results of a multicenter study.  86:458-462. 1992
  • Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery: A report from the Coronary Artery Surgery Study (CASS) registry.  86:446-457. 1992
  • Effect of intravenous adenosine infusion on myocardial perfusion and function: Hemodynamic/angiographic and scintigraphic study.  86:887-895. 1992
  • Effect of pulse separation between two sequential biphasic shocks given over different lead configurations on ventricular defibrillation efficacy.  85:2267-2274. 1992
  • Failure of cryopreserved homograft valved conduits in the pulmonary circulation.  86. 1992
  • Familial lipoprotein disorders in patients with premature coronary artery disease.  85:2025-2033. 1992
  • High-current stimuli to the spared epicardium of a large infarct induce ventricular tachycardia.  85:680-698. 1992
  • Importance of intraluminal pressure on hemodynamics and vasoconstriction responses of stenotic arteries.  85:708-716. 1992
  • Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart.  86:1872-1887. 1992
  • Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia: Evidence for involvement of perinodal myocardium within the reentrant circuit.  85:1675-1688. 1992
  • Surgical connections from ventricle to pulmonary artery: Comparison of four types of valved implants.  86. 1992
  • Three-dimensional potential gradient fields generated by intracardiac catheter and cutaneous patch electrodes.  85:1857-1864. 1992
  • Echocardiographic assessment of prosthetic valves..  84:I228-I239. 1991
  • Endothelium-dependent responses in long-term human coronary artery bypass grafts.  83:402-411. 1991
  • Immediate versus deferred β-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) II-B study.  83:422-437. 1991
  • Induction of myocardial hypertrophy after coronary ligation in rats decreases ventricular dilatation and improves systolic function.  84:1819-1827. 1991
  • Mechanism of cardiac defibrillation: A different point of view.  84:913-919. 1991
  • Relation of risk factor levels in young adulthood to parental history of disease: The CARDIA study.  84:1176-1187. 1991
  • Response of relatively refractory canine myocardium to monophasic and biphasic shocks.  84:2522-2538. 1991
  • Usefulness of transesophageal echocardiography in assessment of aortic dissection.  84:1903-1914. 1991
  • DECLINING STROKE MORTALITY - ESTIMATES OF THE RELATIVE ROLE OF INCIDENCE AND CASE FATALITY.  81:712-712. 1990
  • TREATMENT OF OBESITY HYPERTENSION.  81:723-723. 1990
  • Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator: Results of the thrombolysis in myocardial infarction (TIMI) phase II-A trial.  81:1457-1476. 1990
  • Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study.  81:586-592. 1990
  • Resetting of ventricular tachycardia by single extrastimuli. Relation to slow conduction within the reentrant circuit.  81:1507-1519. 1990
  • Strength-duration and probability of success curves for defibrillation with biphasic waveforms.  82:2128-2141. 1990
  • Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS).  82:1647-1658. 1990
  • Two-dimensional echocardiography and Doppler color flow mapping in the diagnosis and prognosis of ventricular septal rupture.  81:1775-1783. 1990
  • Arrhythmias after orthotopic cardiac transplantation. Prevalence and determinants during initial hospitalization and late follow-up..  80:III140-III146. 1989
  • Arrhythmias after orthotopic cardiac transplantation. Prevalence and determinants during initial hospitalization and late follow-up.  80:140-146. 1989
  • Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry.  79:1171-1179. 1989
  • Risk factors for mortality after primary combined valvular and coronary artery surgery.  79. 1989
  • Cryosurgical ablation of atrioventricular nodal reentry: Histologic localization of the proximal common pathway.  77:1356-1362. 1988
  • Mitral valve prolapse in patients with prior rheumatic fever.  77:830-836. 1988
  • Right ventricular diastolic pressure-volume relations and regional dimensions during acute alterations in loading conditions.  77:1276-1282. 1988
  • Calibration of color Doppler flow mapping during extreme hemodynamic conditions in vitro: A foundation for a reliable quantitative grading system for aortic incompetence.  75:837-846. 1987
  • Color Doppler assessment of mitral regurgitation with orthogonal planes.  75:175-183. 1987
  • Color Doppler evaluation of aortic dissection.  75:748-755. 1987
  • Cryosurgical treatment of atrioventricular node reentrant tachycardia.  76:1329-1336. 1987
  • Electrophysiologic mechanisms underlying arrhythmias due to reperfusion of ischemic myocardium.  76:404-426. 1987
  • Hemodynamically important right ventricular infarction: Follow-up evaluation of right ventricular systolic function at rest and during exercise with radionuclide ventriculography and respiratory gas exchange.  75:996-1003. 1987
  • Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms.  76:1176-1184. 1987
  • Relief of life-threatening ventricular tachycardia and survival after direct operations.  76:93-103. 1987
  • The relationship of various measures of end-systole to left ventricular maximum time-varying elastance in man.  76:32-43. 1987
  • Clinical and prognostic importance of persistent precordial (V1-V4) electrocardiographic ST segment depression in patients with inferior transmural myocardial infarction.  74:56-63. 1986
  • Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability.  73:1022-1028. 1986
  • Intraventricular tunnel repair for Taussig-Bing heart and related cardiac anomalies.  74:53-60. 1986
  • Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia.  74:1266-1279. 1986
  • The effect of chemical ablation of the endocardium on ventricular fibrillation threshold.  74:645-652. 1986
  • The potential gradient field created by epicardial defibrillation electrodes in dogs.  74:626-636. 1986
  • Intermediate-term results of coronary artery bypass grafting for acute myocardial infarction..  72. 1985
  • Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction.  72:1327-1335. 1985
  • Immediate functional recovery and avoidance of reperfusion injury with surgical revascularization of short-term coronary occlusion.  72:431-439. 1985
  • Validation of attenuation-corrected equilibrium radionuclide angiographic determinations of right ventricular volume: Comparison with cast-validated biplane cineventriculography.  72:317-326. 1985
  • A randomized comparison of crystalloid and blood-containing cardioplegic solutions in 60 patients.  69:973-982. 1984
  • Comparison of enzymatic and anatomic estimates of myocardial infarct size in man.  70:824-835. 1984
  • Prosthetic valve endocarditis.  69:223-232. 1984
  • Return of left ventricular function after reperfusion in patients with myocardial infarction: Importance of subtotal stenoses or intact collaterals.  69:338-349. 1984
  • A life table and Cox regression analysis of patients with combined proximal left anterior descending and proximal left circumflex coronary artery disease: Non-left main equivalent lesions (CASS).  68:1163-1170. 1983
  • A mechanism of torsades de pointes in a canine model.  67:52-59. 1983
  • Correlation of echocardiographic wall stress and left ventricular pressure and function in aortic stenosis.  67:854-859. 1983
  • Variation in the size of jeopardized myocardium in patients with isolated left anterior descending coronary artery disease.  67:988-994. 1983
  • Costs and benefits associated with treatment for coronary artery disease.  66. 1982
  • Epidemiologic study of candidates for coronary artery bypass surgery..  66:III6-II15. 1982
  • Assessment of jeopardized myocardium in patients with one-vessel disease.  65:242-247. 1982
  • Employment status after coronary artery bypass surgery.  65. 1982
  • Epidemiologic study of candidates for coronary artery bypass surgery.  66. 1982
  • Evaluation of a QRS scoring system for estimating myocardial infarct size. I. Specificity and observer agreement.  65:342-347. 1982
  • Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man.  66:49-55. 1982
  • Two-dimensional echocardiographic features of right ventricular infarction.  65:167-173. 1982
  • Treatment of infective endocarditis due to viridans streptococci. This statement was prepared by the ad hoc subcommittee on treatment of bacterial endocarditis of the American Heart Association Council on cardiovascular disease in the young.  63. 1981
  • A simplified valve formula for the calculation of stenotic cardiac valve areas.  63:1050-1055. 1981
  • Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS).  64:360-367. 1981
  • Correlation of the width of the QRS complex with the pathologic anatomy of the cardiac conduction system in patients with chronic complete atrioventricular block.  63:938-947. 1981
  • Myocardial infarct size and location in relation to the coronary vascular bed at risk in man.  64:526-534. 1981
  • Real-time, two-dimensional echocardiographic features of pacemaker perforation.  64:97-106. 1981
  • The transition to ventricular fibrillation induced by reperfusion after acute ischemia in the dog: A period of organized epicardial activation.  63:1371-1379. 1981
  • Two-dimensional echocardiographic features of atrial septal aneurysms.  63:452-457. 1981
  • Two-dimensional echocardiographic identification of papillary muscles..  64:651-652. 1981
  • Surgical vs nonsurgical management of patients after myocardial infarction.  62. 1980
  • Detection of residual jeopardized myocardium 3 weeks after myocardial infarction by exercise testing with thallium-201 myocardial scintigraphy.  61:729-737. 1980
  • Drug management of hypertension.  61:210-212. 1980
  • Quantitative difference in 'critical' stenosis between right and left coronary artery in man.  62:1188-1196. 1980
  • Preoperative evaluation of subvalular fibrosis in mitral stenosis. A predictor factor in conservative vs replacement surgical therapy..  60:71-76. 1979
  • A computerized method for the rapid display of ventricular activation during the intraoperative study of arrhythmias.  59:449-458. 1979
  • Effect of filming projection and interobserver variability on angiographic biplane left ventricular volume determination.  59:96-104. 1979
  • Epicardial mapping of the onset of ventricular tachycardia initiated by programmed stimulation in the canine heart with chronic infarction.  60:1375-1384. 1979
  • Impaired maximal rate of left ventricular relaxation in patients with coronary artery disease and left ventricular dysfunction.  59:984-991. 1979
  • Preoperative evaluation of subvalvular fibrosis in mitral stenosis. A predictive factor in conservative vs replacement surgical therapy.  60. 1979
  • Unstable angina pectoris. An examination of modes and costs of therapy.  60. 1979
  • Usefulness and limitations of thallium-201 myocardial scintigraphy in delineating location and size of prior myocardial infarction.  59:1010-1019. 1979
  • Anomalous aortic origin of coronary arteries.  58:606-615. 1978
  • Changes in left ventricular segmental wall motion following randomization to medicine or surgery in patients with unstable angina..  58. 1978
  • Chronotropic effects of tetraethylammonium and 4-aminopyridine in canine sinus node pacemaker cells.  58. 1978
  • Echocardiographic evaluation of intracardiac pacing catheters: M-mode and two-dimensional studies.  58:1049-1056. 1978
  • Effect of glucose-insulin-potassium infusion during pacing.  58. 1978
  • Evaluation of asynergy as an indicator of myocardial fibrosis.  57:715-725. 1978
  • Left ventricular aneurysmectomy in patients with single vs multivessel coronary artery disease..  58. 1978
  • The bruit of carotid stenosis versus radiated basal heart murmurs: Differentiation by phonoangiography.  57:975-981. 1978
  • The mechanism of post-arrhythmic renal vasoconstriction in the dog.  58. 1978
  • Treatment of infective endocarditis: A 10-year comparative analysis.  58:589-597. 1978
  • Correlation of angiographic estimates of myocardial infarct size and accumulated release of creatine kinase MB isoenzyme in man.  56:199-205. 1977
  • Correlation of postmortem anatomic findings with electrocardiographic changes in patients with myocardial infarction. Retrospective study of patients with typical anterior and posterior infarcts.  55:279-285. 1977
  • Improved outcome for prehospital cardiopulmonary collapse with resuscitation by bystanders.  56:901-905. 1977
  • Left precordial isopotential mapping during supine exercise.  56:245-252. 1977
  • Quantitative assessment of ventricular performance in unstable ischemic heart disease by dextran function curves.  55:858-863. 1977
  • Technetium 99m stannous pyrophosphate myocardial scintigraphy. Reliability and limitations in assessment of acute myocardial infarction.  56:192-198. 1977
  • Glucose insulin potassium, free fatty acids and acute myocardial infarction in man.  53. 1976
  • Anginal threshold and glucose-insulin-potassium in unstable ischemic heart disease.  54. 1976
  • Echocardiographic studies of abnormalities associated with coarctation of the aorta.  53:953-956. 1976
  • Echocardiography of cardiac valves in pericardial effusion.  54:500-504. 1976
  • Influence of [Mg2+] on activity of sinus node pacemaker cells.  54. 1976
  • Sinus bradyarrhythmia and impaired response to norepinephrine caused by low extracellular sodium.  54. 1976
  • Structural requirements for the inhibition of renin release in vitro by the angiotensins.  54. 1976
  • Simultaneous operative correction of aortic valve stenosis and idiopathic hypertrophic subaortic stenosis.  52:34-39. 1975
  • Analysis of components in a cardiogenic hyertensive chemoreflex.  52:179-192. 1975
  • Canine atrial and ventricular muscle mechanics studied as a function of age.  52. 1975
  • Echocardiographic features of subpulmonic obstruction in dextro transposition of the great vessels.  51:515-521. 1975
  • Echocardiography of the intra atrial baffle in dextro transposition of the great vessels.  51:1130-1135. 1975
  • Echocardiography of the tricuspid valve in congenital left ventricular right atrial communication.  51:268-272. 1975
  • Localization of heart vectors produced by pairs of epicardial burns: validation of a two dipole ranging method.  52. 1975
  • Mitral commissurotomy versus replacement. Preoperative evaluation by echocardiography.  51:263-267. 1975
  • Echocardiographic evaluation of pulmonary hypertension.  50:575-581. 1974
  • Echocardiographic recognition of the congenital bicuspid aortic valve.  49:870-875. 1974
  • Echocardiography in the diagnosis of idiopathic hypertrophic subaortic stenosis co existing with aortic valve disease.  50:752-757. 1974
  • Morphine selectively perfused into the sinus node of awake dogs.  50. 1974
  • Diagnosis of aortic root dissection by echocardiography.  48:506-513. 1973
  • Echocardiographic assessment of left ventricular outflow width in the selection of mitral valve prosthesis..  48:1208-1214. 1973
  • Prosthetic valve endocarditis: analysis of 38 cases.  48:365-377. 1973
  • Decreased carotid flow with ascending aortic cannulation..  45. 1972
  • Role of renin in acute postural homeostasis..  41:89-95. 1970
  • International Standard Serial Number (issn)

  • 0009-7322
  • 1524-4539
  • Electronic International Standard Serial Number (eissn)

  • 1524-4539